Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction*

Background: Mitochondrial dysfunction and aggregation of α-synuclein both contribute to Parkinson disease. Results: Prefibrillar α-synuclein oligomers reduce the Ca2+ retention time of isolated mitochondria respiring with complex I but not II substrates. Conclusion: Oligomeric α-synuclein promotes mitochondrial dysfunction in a Ca2+- and respiratory substrate-dependent manner. Significance: The Ca2+-dependence of α-synuclein's effects may contribute to selective neuronal vulnerability in Parkinson disease. α-Synuclein (αSyn) aggregation and mitochondrial dysfunction both contribute to the pathogenesis of Parkinson disease (PD). Although recent studies have suggested that mitochondrial association of αSyn may disrupt mitochondrial function, it is unclear what aggregation state of αSyn is most damaging to mitochondria and what conditions promote or inhibit the effect of toxic αSyn species. Because the neuronal populations most vulnerable in PD are characterized by large cytosolic Ca2+ oscillations that burden mitochondria, we examined mitochondrial Ca2+ stress in an in vitro system comprising isolated mitochondria and purified recombinant human αSyn in various aggregation states. Using fluorimetry to simultaneously measure four mitochondrial parameters, we observed that soluble, prefibrillar αSyn oligomers, but not monomeric or fibrillar αSyn, decreased the retention time of exogenously added Ca2+, promoted Ca2+-induced mitochondrial swelling and depolarization, and accelerated cytochrome c release. Inhibition of the permeability transition pore rescued these αSyn-induced changes in mitochondrial parameters. Interestingly, the mitotoxic effects of αSyn were specifically dependent upon both electron flow through complex I and mitochondrial uptake of exogenous Ca2+. Our results suggest that soluble prefibrillar αSyn oligomers recapitulate several mitochondrial phenotypes previously observed in animal and cell models of PD: complex I dysfunction, altered membrane potential, disrupted Ca2+ homeostasis, and enhanced cytochrome c release. These data reveal how the association of oligomeric αSyn with mitochondria can be detrimental to the function of cells with high Ca2+-handling requirements.


␣-Synuclein (␣Syn) aggregation and mitochondrial dysfunction both contribute to the pathogenesis of Parkinson disease (PD).
Although recent studies have suggested that mitochondrial association of ␣Syn may disrupt mitochondrial function, it is unclear what aggregation state of ␣Syn is most damaging to mitochondria and what conditions promote or inhibit the effect of toxic ␣Syn species. Because the neuronal populations most vulnerable in PD are characterized by large cytosolic Ca 2؉ oscillations that burden mitochondria, we examined mitochondrial Ca 2؉ stress in an in vitro system comprising isolated mitochondria and purified recombinant human ␣Syn in various aggregation states. Using fluorimetry to simultaneously measure four mitochondrial parameters, we observed that soluble, prefibrillar ␣Syn oligomers, but not monomeric or fibrillar ␣Syn, decreased the retention time of exogenously added Ca 2؉ , promoted Ca 2؉ -induced mitochondrial swelling and depolarization, and accelerated cytochrome c release. Inhibition of the permeability transition pore rescued these ␣Syninduced changes in mitochondrial parameters. Interestingly, the mitotoxic effects of ␣Syn were specifically dependent upon both electron flow through complex I and mitochondrial uptake of exogenous Ca 2؉ . Our results suggest that soluble prefibrillar ␣Syn oligomers recapitulate several mitochondrial phenotypes previously observed in animal and cell models of PD: complex I dysfunction, altered membrane potential, disrupted Ca 2؉ homeostasis, and enhanced cytochrome c release. These data reveal how the association of oligomeric ␣Syn with mitochondria can be detrimental to the function of cells with high Ca 2؉ -handling requirements.
Parkinson disease (PD), 2 the second most common neurodegenerative disease, is characterized by the conversion of the normally soluble cytoplasmic protein ␣-synuclein (␣Syn) into insoluble amyloid fibrils that accumulate as cytoplasmic aggregates termed Lewy bodies and Lewy neurites (1). Duplication or triplication of the wild-type ␣Syn locus causes gene dose-dependent early onset PD (2,3), and five pathogenic missense mutations have been reported to cause autosomal dominant PD (4). Moreover, 3Ј-UTR variants and other single nucleotide polymorphisms in the SNCA gene that lead to increased ␣Syn expression are found in a subset of cases of sporadic PD (5). In addition, mutations in glucocerebrosidase (GBA1), the most common genetic risk factor for PD, can elevate ␣Syn protein levels, perhaps via reduced lysosomal degradation (6). Thus, impaired proteostasis of ␣Syn is probably a key step in the pathogenesis of PD and related human synucleinopathies.
A growing body of evidence suggests that ␣Syn normally exits in an equilibrium between partially helical tetramers and unfolded monomers (7)(8)(9)(10). Helical, oligomeric ␣Syn is aggregation-resistant in vitro (7), whereas the unfolded monomer readily aggregates into insoluble, ␤-sheet-rich amyloid-type fibrils through soluble oligomeric intermediates (11). Recent studies indicate that these abnormal soluble oligomers, in contrast to the fibrillar end products, are neurotoxic in vitro and in disease models (12)(13)(14)(15). The pathological mechanisms of these toxic oligomeric intermediates and the basis for the selective vulnerability of certain brain regions to their effects are as yet undetermined.
Many observations suggest that mitochondrial dysfunction is associated with PD. Toxins targeting complex I of the electron transport chain (ETC) can cause parkinsonism in humans and animal models (16 -18), and postmortem brain tissue of PD patients shows deficits in mitochondrial complex I activity (19 -21). Markers of mitochondrial oxidative stress, including oxidized complex I subunits (22) and mitochondrial DNA mutations (23), are also elevated in PD patients, although it is unclear whether these are a cause or consequence of ETC dysfunction. The neuronal populations most impaired in PD, including the substantia nigra pars compacta, locus ceruleus, and dorsal motor nucleus of the vagus, share an unusual phys-iological phenotype; they consist primarily of broad-spike pacemaking neurons with high transmembrane Ca 2ϩ currents and low Ca 2ϩ buffering capacities (24). This combination places a great metabolic burden on mitochondria to continually reestablish the resting cytosolic Ca 2ϩ concentration. Mitochondria-targeted, redox-sensitive GFP reveals a more oxidative mitochondrial environment in these neurons relative to those of regions less affected in PD (25,26). The basal level of oxidant stress in the mitochondria of vulnerable neurons may put them at risk of dysfunction caused by an additional stressor.
␣Syn may associate abnormally with mitochondria in PD patients and animal models (27)(28)(29)(30)(31)(32)(33). An apparent partial subcellular redistribution of ␣Syn from the cytoplasm to the inner and outer mitochondrial membranes (27,34,35) is correlated with mitochondrial dysfunction, including increased oxidative stress, reduced mitochondrial membrane potential (⌬⌿ m ), altered Ca 2ϩ homeostasis, and cytochrome c release (27, 29 -31, 33, 36, 37). Few studies have directly investigated the effect of different forms of ␣Syn on mitochondrial function. One reported that incubation of isolated mitochondria with aggregated ␣Syn can increase markers of oxidative stress, but the aggregation state (fibrillar or oligomeric) was not thoroughly characterized (36). No previous studies have tested the role of mitochondrial Ca 2ϩ stress or specific respiratory substrates in the ability of diverse ␣Syn species to induce mitochondrial dysfunction. It therefore remains unclear what form of ␣Syn is most damaging to mitochondrial function and which conditions promote or inhibit the effect of toxic ␣Syn species.
We sought to investigate the functional consequences of ␣Syn on Ca 2ϩ -challenged mitochondria, with a particular focus on the ␣Syn aggregation state. We modeled mitochondrial Ca 2ϩ stress in an in vitro system comprising isolated mitochondria from liver and brain and pure, recombinant human ␣Syn at various aggregation states. Soluble, oligomeric ␣Syn aggregates generated by two independent methods, but not monomeric ␣Syn or mature fibrils, sensitized mitochondria to Ca 2ϩ -induced dysfunction. The effects of oligomeric ␣Syn were observed only when mitochondria were respiring under complex I-dependent conditions and were challenged with exogenous Ca 2ϩ addition. Our results demonstrate a specific effect of oligomeric ␣Syn on complex I-dependent function and reveal a mechanism by which the physical association of ␣Syn with mitochondria impairs their function.

Purification and Preparation of ␣Syn Species
Purification-Recombinant human ␣Syn was purified essentially as described (38). Briefly, E. coli transformed with human wild type ␣Syn were grown to A 600 ϭ 0.5-1, at which time isopropyl 1-thio-␤-D-galactopyranoside was added to 1 mM to induce ␣Syn expression. At A 600 ϭ 1.5-1.8, bacteria were pelleted by centrifugation and boiled in anion exchange buffer (20 mM Tris, 25 mM NaCl, pH 8.0). Boiled bacterial lysate was purified sequentially by anion exchange chromatography (using two 5-ml HiTrap Q HP columns, GE Healthcare) and size exclusion chromatography (using a Superdex 200 XK26/00 column, GE Healthcare). Protein not used immediately was lyoph-ilized and stored at 4°C. Lyophilized protein was reconstituted either in PBS or 10 mM ammonium acetate, depending on the method used to prepare oligomers (see below).
Lag Phase Preparation-0.6 mg/ml recombinant ␣Syn in 10 mM ammonium acetate was incubated at 37°C with nutation.
The aggregation state was monitored using Thioflavin T (ThT) fluorescence (see below). "Unaged" ␣Syn was sampled at time 0 (prior to 37°C incubation or nutation). ␣Syn aged 3-9 days without ThT fluorescence above background was considered "ThT neg "; ␣Syn that had plateaued in ThT fluorescence was considered "ThT pos ." Sonicated Preparation-2 mg/ml recombinant ␣Syn in PBS was aggregated for 5 days at 37°C with nutation to form ThT pos fibrils. To generate oligomers, ␣Syn fibrils were diluted to 1 mg/ml and sonicated at power level 50 for 5 ϫ 10 s using a Sonic Dismembrator model 300 (Fisher). Aliquots of the resultant material were flash-frozen in liquid nitrogen and stored at Ϫ80°C. Fractions of this material were prepared by serial differential centrifugation, first at 16,000 ϫ g for 5 min. The supernatant was transferred to a new tube, and the pellet was resuspended in an equal volume of PBS. The 16,000 ϫ g supernatant was then spun at 100,000 ϫ g for 30 min at 4°C. The supernatant was transferred to a new tube, and the pellet was resuspended in an equal volume of PBS. The use of a programmable Ultrasonic Liquid Processor (Misonix) equipped with a microtip (settings: amplitude of 20, sonication for 1 s on and 1 s off for a total of 60 s) also produced ␣Syn oligomers with bioactivity on mitochondria comparable with the bioactivity of oligomers produced via our standard manual sonication technique. For both sonicated and lag phase preparations, concentrations of fibrillar and oligomeric ␣Syn listed are estimated based on the monomer concentration before aggregation as determined by A 280 using a NanoDrop spectrophotometer (Thermo Scientific).

Electron Microscopy
␣Syn fibrils, total sonicated ␣Syn, and 100,000 ϫ g soluble sonicated ␣Syn were each diluted 1:10 in PBS. 5 l of these ␣Syn samples were adsorbed for 1 min to a carbon-coated grid that had been made hydrophilic by a 30-s exposure to a glow discharge. Excess liquid was removed with filter paper (Whatman), and the samples were stained with 0.75% uranyl formate for 30 s. After removing the excess uranyl formate with filter paper, the grids were examined using a TecnaiG 2 Spirit BioT-WIN transmission electron microscope. Images were acquired with an AMT 2k CCD camera.
Aliquots of mitochondrial suspensions (see below) were spun at 14,000 ϫ g for 5 min to pellet mitochondria. Mitochondrial pellets were fixed in 2.5% glutaraldehyde, 1.25% paraformaldehyde, and 0.03% picric acid in 0.1 M sodium cacodylate buffer (pH 7.4) for at least 2 h at room temperature and then washed in 0.1 M cacodylate buffer and postfixed with 1% osmium tetroxide (OsO 4 ), 1.5% potassium ferrocyanide (KFeCN 6 ) for 1 h. Samples were then washed three times in H 2 O and incubated in 1% aqueous uranyl acetate for 1 h followed by two washes in H 2 O and subsequent dehydration in grades of alcohol (10 min each: 50%, 70%, 90%: twice for 10 min each: 100%). The samples were then put in propylene oxide for 1 h and infiltrated overnight in a 1:1 mixture of propylene oxide and TAAB Epon (Marivac Canada Inc., St. Laurent, Canada). The following day, the samples were embedded in TAAB Epon and polymerized at 60°C for 48 h. Ultrathin sections (ϳ60 nm) were cut on a Reichert Ultracut-S microtome and transferred onto copper grids stained with lead citrate. Sections were examined in a JEOL 1200EX Transmission electron microscope or a TecnaiG 2 Spirit BioTWIN, and images were recorded with an AMT 2k CCD camera. Measurements of mitochondrial diameter were obtained using ImageJ (National Institutes of Health).

Dynamic Light Scattering
Experiments were performed using a DynaPro (Wyatt Technology) instrument equipped with a 20°C temperature-controlled microsampler. ␣Syn samples in PBS were placed in a 1.5-mm path length quartz cuvette, and light scattering was measured in 10-s intervals for 20 cycles. Data were analyzed using Dynamic version 5 software.

Thioflavin T Assays
2.5 M ␣Syn at various aggregation states (i.e. unaged/monomer, fibrils, sonicated oligomers and fractions thereof, and lag phase samples) was added in triplicate to 10 M ThT in 10 mM glycine buffer, pH 9, to a total of 200 l. Fluorescence at excitation/emission of 447/485 nm was measured in a black 96-well plate using the Synergy H1 Hybrid Reader (BioTek). Background fluorescence of buffer (PBS or 10 mM ammonium acetate) was subtracted from ␣Syn-containing samples. For aggregation seeding assays, 100 l of 7-20 M monomeric ␣Syn in PBS plus 1 mol % of ␣Syn "seeds" at various aggregation states and 10 M ThT were added in triplicate to a black 96-well plate. Plates were incubated at 37°C under constant agitation at 300 rpm using a titer plate shaker (Lab Line Instruments). ThT fluorescence at excitation/emission of 447/485 nm was measured periodically as above.

Mitochondrial Isolation
All chemicals were purchased from Sigma-Aldrich unless stated otherwise. All procedures for animal use and euthanasia were approved by the institutional animal care and use committee. Liver mitochondria were isolated from ϳ11-13-week-old mice by the standard differential centrifugation method in sucrose-based buffers as described previously (39,40) with some modifications. Briefly, the liver was homogenized in a buffer containing 240 mM sucrose, 10 mM K ϩ -HEPES, pH 7.4, 1 mM K ϩ -EGTA, and 0.5% fatty acid-free bovine serum albumin (BSA) and centrifuged at 1,000 ϫ g for 10 min. The supernatant was then centrifuged for 8 min at 8,000 ϫ g. The resulting pellet was resuspended in the same buffer and centrifuged for 8 min at 8,000 ϫ g. The pellet from this spin was resuspended in 240 mM sucrose, 10 mM K ϩ -HEPES, pH 7.4, and centrifuged again for 8 min at 8,000 ϫ g. The final mitochondrial pellet was resuspended in 0.2 ml of 240 mM sucrose, 10 mM K ϩ -HEPES, pH 7.4. All centrifugation steps were performed at 4°C. Mitochondrial protein concentration was determined by the DC protein assay (Bio-Rad) using BSA as a standard. The quality of isolated mitochondria was assessed by the respiratory control ratio, calculated as the ratio between the rates of respiration in states 3 (ADP-stimulated) and 4 (ADP-exhausted) (41). The respiratory control ratio for mitochondria used in this study was measured to be 4.9 Ϯ 0.18 under the following conditions: 10 mM succinate, 1 M rotenone, and 200 M ADP.
Non-synaptosomal brain mitochondria were isolated from ϳ4 -5-week-old mice using a discontinuous Ficoll gradient according to the commonly used method of Lai and Clark (42), with slight modifications as described previously (40). Briefly, the cerebral corticies from 10 -12 mice were homogenized in a buffer containing 320 mM sucrose, 10 mM K ϩ -HEPES, pH 7.4, 1 mM K ϩ -EGTA, and 0.2% BSA and centrifuged at 2,000 ϫ g for 3 min. The supernatant was then centrifuged again for 3 min at 2,000 ϫ g and then for 8 min at 12,000 ϫ g. The pellet from this spin was resuspended in 5 ml of 320 mM sucrose, 10 mM K ϩ -HEPES, pH 7.4, 1 mM K ϩ -EGTA buffer, layered on Ficoll gradient (7.5%/10%), and centrifuged again for 12 min at 100,000 ϫ g (23,400 rpm; Beckman ultracentrifuge with swinging rotor SW28). The resulting pellet was resuspended in 240 mM sucrose, 10 mM K ϩ -HEPES buffer and centrifuged for 8 min at 12,000 ϫ g. This step was performed twice. The final mitochondrial pellet was resuspended in 0.05 ml of 240 mM sucrose, 10 mM K ϩ -HEPES, pH 7.4.

Measurement of Mitochondrial Ca 2؉ Uptake Capacity, Membrane Potential, NAD(P)H Oxidation, and Swelling
All chemicals were purchased from Sigma-Aldrich unless stated otherwise. The measurement of these parameters was performed simultaneously on a multichannel dye fluorimeter (C&L Instruments, Inc.) as described previously (39,40). Liver mitochondria were incubated in buffer containing 240 mM sucrose, 10 mM HEPES, pH 7.2, 1 mM KH 2 PO 4 , 3 M EDTA, and either 5 mM glutamate/malate or 5 mM succinate plus 1 M rotenone and were used at a concentration of 0.25 mg of mitochondrial protein/ml. Changes to mitochondrial membrane potential (⌬⌿ m ) were estimated by measuring changes in the fluorescence intensity of tetramethylrhodamine methyl ester (TMRM) (60 nM) (Invitrogen) at excitation and emission wavelengths of 543 and 590 nm, respectively. Mitochondrial Ca 2ϩ flux was measured as change in extramitochondrial Ca 2ϩ concentration, measured by fluorescence of CaGreen-5N (125 nM) (Invitrogen) at excitation and emission wavelengths of 482 and 535 nm, respectively. The redox state of pyridine nucleotides in the mitochondrial suspension was followed by monitoring NAD(P)H autofluorescence at excitation and emission wavelengths of 350 and 450 nm, respectively. Mitochondrial swelling was measured by light scattering at a wavelength of 587 nm. Mitochondria were challenged by single Ca 2ϩ additions of 20 -40 nmol Ca 2ϩ /mg mitochondrial protein. Mitochondrial Ca 2ϩ retention time (CRT) was defined as the time between the Ca 2ϩ addition and the plateau in CaGreen-5N fluorescence. To induce maximal swelling, the nonspecific pore-forming agent alamethicin was added to a final concentration of 2.5 M at the conclusion of each run.
Measurements of Ca 2ϩ retention capacity (CRC) in isolated brain mitochondria in the presence or absence of ␣Syn were achieved by incubating mitochondria in buffer containing 100 mM sucrose, 75 mM KCl, 10 mM HEPES, pH 7.4, 3 M EDTA, 2 mM KH 2 PO 4 , 150 M ATP, 150 M MgCl 2 . Mitochondrial parameters were measured as mentioned above for liver mitochondria. Mitochondria were challenged with multiple Ca 2ϩ additions of 10 nmol Ca 2ϩ /mg mitochondrial protein. CRC was defined as the maximum amount of Ca 2ϩ that could be completely buffered by mitochondria as measured by the return to baseline fluorescence. Fluorimeter data were analyzed using Origin version 8.0 (OriginLab) software. The specific conditions of each experiment (i.e. substrates, inhibitors, concentration of Ca 2ϩ or other mitochondrial permeability transition pore (mPTP) inducers, and ␣Syn species) are noted throughout. CRT and CRC were normalized to vehicle control.

Measurement of Hydrogen Peroxide (H 2 O 2 ) Production
H 2 O 2 production in brain mitochondria was detected by fluorescence of the oxidized Amplex Red (Invitrogen) product using excitation and emission wavelengths of 550 and 585 nm, respectively (43). The assay buffer contained 75 mM KCl, 100 mM sucrose, 10 mM K ϩ -HEPES, 3 M EDTA, 2 mM KH 2 PO 4, 150 M ATP, 150 M MgCl 2 , 1 M Amplex Red, 5 units/ml horseradish peroxidase, 40 units/ml superoxide dismutase. Mitochondria were added to a final concentration of 0.125 mg/ml. The response of Amplex Red to H 2 O 2 was calibrated by sequential additions of a known amount of H 2 O 2 prepared as described (43).

Complex I Activity Assay
The activity of mitochondrial complex I was determined by measuring the rotenone-sensitive oxidation of NADH as described (44). Briefly, the decrease in autofluorescence of reduced NADH was monitored at 340 nm and at 30°C using a SpectraMax Plus 384 spectrophotometer (Molecular Devices). 50 g of liver mitochondria were resuspended in 70 l of hypotonic medium B (25 mM KH 2 PO 4 , 5 mM MgCl 2 ) and sonicated four times for 1 s each using a Sonic Dismembrator model 300 (Fisher) at power level 40 at 4°C. The mitochondrial suspension was then added to a quartz spectrophotometric cell containing 10 mM potassium phosphate (pH 7.2), 5 mM MgCl 2 , 2 mM KCN (prepared fresh), 2.5 mg/ml BSA, 0.13 mM NADH, 2 g/ml antimycin A, 65 M coenzyme Q1, plus either a 1 M concentration of the various ␣Syn species tested (monomer, fibrils, and sonicated fibrils) or an equivalent volume of vehicle. The absorbance was measured for 3 min. 5 g/ml rotenone was then added to inhibit complex I activity, and absorbance was measured for an additional 3 min. The post-rotenone slope was subtracted from the pre-rotenone slope to determine the rotenone-sensitive oxidation rate. The rotenone-sensitive rates of oxidation in the presence of various ␣Syn species were normalized to vehicle-treated mitochondria for each experiment.

Assessment of Mitochondrial Cytochrome c Release
30-l aliquots were removed from vehicle-and ␣Syn-treated mitochondrial suspensions used for fluorescence analysis of mitochondrial parameters (see above) at time points corresponding approximately to 25, 50, 75, and 100% swelling of vehicle-treated mitochondria. Another aliquot was removed following the addition of 2.5 M alamethicin, which was used to induce maximal swelling and cytochrome c release. Aliquots were centrifuged for 5 min at 14,000 ϫ g to pellet intact mito-chondria. 12 l of the supernatant were added to LDS sample buffer containing 5% ␤-mercaptoethanol and analyzed by SDS-PAGE/Western blot for released, soluble cytochrome c.

Assessment of Mitochondria-associated ␣Syn
Mitochondria were incubated as described for fluorescence measurements of mitochondrial parameters. In all cases, glutamate/malate and ␣Syn were added to the mitochondrial suspension. 20 M Ca 2ϩ or an equivalent volume of water was added 2 min after ␣Syn, and after an additional 5 min, 200-l aliquots of the suspension were removed. Aliquots were spun at 8,000 ϫ g for 10 min to pellet mitochondria, and the supernatant was removed. Mitochondrial pellets were washed four times in 50 l of assay buffer without substrates, after which they were lysed with 50 l of 1% Nonidet P-40 lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 10 mM EDTA, 1% (v/v) Nonidet P-40, complete mini-EDTA-free protease inhibitor tablet) for 25 min on ice. Lysed mitochondria were spun for 5 min at 6,000 ϫ g, and the supernatant was collected. The supernatants of the mitochondrial suspension, washes, and lysed mitochondrial pellets were analyzed by SDS-PAGE/Western blot for ␣Syn. To quantify the total ␣Syn immunoreactivity of lysed mitochondrial pellets, densitometric analysis was performed using ImageJ (National Institutes of Health).

SDS-PAGE/Western Blotting
Samples for Western blotting were electrophoresed on NuPAGE 4 -12% BisTris gels (Invitrogen) with MES-SDS running buffer. Gels were then transferred onto 0.45-m Immobilon-P PVDF membranes (Millipore) for 60 min at 400-mA constant current at 4°C in transfer buffer consisting of 25 mM Tris, 192 mM glycine, and 20% methanol. After transfer, membranes were blocked in 5% nonfat milk in PBS with 0.1% (v/v) Tween 20 (PBS-T) for 30 min at room temperature and then incubated in primary antibody either overnight at 4°C or for 60 min at room temperature. Membranes were then washed three times for 5 min in PBS-T, incubated with secondary antibody, washed three more times for 5 min in PBS-T, and then developed with ECL Plus or ECL Prime (GE Healthcare) according to the manufacturer's directions.

Antibodies
2F12, an in-house generated mouse monoclonal antibody against ␣Syn (9), was used at 0.18 g/ml in PBS-T plus 5% milk. The mouse monoclonal anti-cytochrome c antibody 7H8 (Santa Cruz Biotechnology, Inc.) was used at 200 ng/ml in PBS-T plus 1% milk. Horseradish peroxidase-conjugated mouse secondary antibody (GE Healthcare) was diluted 1:10,000 in PBS-T plus 1% milk.

Statistical Analysis
Data are presented as the mean Ϯ S.D. unless otherwise specified. Comparisons across two groups were made using an unpaired t test. When three or more groups were compared, a one-way ANOVA followed by Tukey's multiple-comparison test were used. Data are considered significant at a p value of Յ0.05.
␣Syn Promotes Ca 2؉ -and Complex I-dependent Mitotoxicity AUGUST

Prefibrillar Thioflavin T-negative ␣Syn Promotes Complex I-dependent, Ca 2ϩ -mediated Mitochondrial Dysfunction-To
assess whether ␣Syn can directly compromise mitochondrial function, we prepared recombinant human ␣Syn for application to isolated mitochondria. To this end, we monitored the aggregation state of ␣Syn solutions incubated at 37°C under nutation. Assaying ␣Syn at different time points in this in vitro "aging" process using the amyloid binding dye ThT produced a sigmoidal curve of ThT fluorescence (Fig.  1A). We compared unaged monomer, aged ThT-negative (ThT neg ) ␣Syn sampled during the aggregation lag phase and ThT-positive (ThT pos ) aggregates ( Fig. 1A, blue, red, and green, respectively) for their ability to alter the function of mitochondria. We hypothesized that ThT neg ␣Syn from the aggregation lag phase would be bioactive when applied to the isolated mitochondria, because this phase is characterized by the presence of soluble oligomers (45)(46)(47) that are believed to be more toxic than ThT pos fibrils that are abundant at the end stage of aggregation.
Mitochondrial stress was modeled by exposing isolated mitochondria to a single bolus of Ca 2ϩ to induce eventual membrane permeabilization associated with a collapse of ⌬⌿ m , release of endogenous and exogenously administered Ca 2ϩ , oxidation of pyridine nucleotides, and mitochondrial swelling. We used a fluorimeter-based assay to simultaneously measure these four parameters (⌬⌿ m , Ca 2ϩ uptake/release, redox state of NAD(P)H, and swelling) in isolated mouse liver mitochondria. Fig. 1B shows a representative record of these four mitochondrial parameters for mitochondria respiring with the complex I substrates glutamate and malate (complex I conditions) and exposed to a single Ca 2ϩ addition in the absence (black traces) or the presence of 1 M monomeric (blue traces) or aged, ThT neg ␣Syn (red traces). The addition of mitochondria into the incubation buffer, as indicated by the labeled arrow, induced the sharp decline of the TMRM signal (i.e. TMRM concentration in the buffer) due to the accumulation and quenching of the dye by polarized mitochondria. The addition of Ca 2ϩ at 180 s induced a transient depolarization (and therefore increase of TMRM signal) as well as a spike in extramitochondrial Ca 2ϩ concentration before rapid uptake into mitochondria. Alamethicin, a nonspecific pore-forming agent, was added as a positive control to observe maximal mitochondrial swelling at the end of these measurements (note the rapid reduction in absorbance at 587 nm). Unaged, monomeric ␣Syn had no effect on mitochondrial CRT, whereas 1 M ThT neg ␣Syn significantly reduced mitochondrial CRT by 27% versus control (Fig. 1C). ␣Syn sampled from the end-stage plateau of aggregation (ThT pos ) failed to reduce mitochondrial CRT (Fig.  1D). Taken together, these data suggest that partially aged ThT neg ␣Syn, but not monomeric or highly aggregated ThT pos ␣Syn, sensitizes mitochondria to Ca 2ϩ -mediated mitochondrial dysfunction.
Because the level of mitochondria-localized ␣Syn has been inversely correlated with complex I activity in the substantia nigra of PD patients (27), we investigated whether the effect of prefibrillar ␣Syn was restricted to complex I conditions. Therefore, instead of the complex I substrates glutamate and malate, we added the complex II substrate succinate and complex I inhibitor rotenone (complex II conditions). Interestingly, under complex II conditions, neither ThT neg nor monomeric ␣Syn significantly affected CRT (Fig. 1C) or the other mito-chondrial parameters tested (data not shown). This result suggests that the ability of aged ThT neg ␣Syn to sensitize mitochondria to Ca 2ϩ is specifically dependent on electron flow through complex I and also serves as an important specificity control for our analytical method.
Duration of the Aggregation Lag Phase Is Variable-The data presented in Fig. 1 highlight the fact that obtaining bioactive ␣Syn is critically dependent on predicting the timing of the aggregation lag phase and "catching" ␣Syn at the optimal oligomerization state. Although the effects of aged, ThT neg ␣Syn occurred consistently, the duration of the aggregation lag phase leading to activity varied considerably and was thus difficult to predict a priori. Five examples of ␣Syn incubated under identical conditions on different days are displayed in Fig. 2. In some cases, the lag phase extended over several days, whereas in others, the samples already contained ThT-binding species at early time points after the start of incubation (Fig. 2, note the broken abscissa). The kinetics of ␣Syn aggregation are known to be altered by many factors, including pH, temperature, sample volume, degree of agitation, protein concentration, and the presence of even a small amount of oligomeric "seeds." We therefore sought a more reproducible way of generating bioactive oligomers.
Characterization of ␣Syn Fibrils before and after Sonication-Sonicated ␣Syn fibrils have recently been used to seed the aggregation of endogenous ␣Syn in cells and mice (48,49).  ␣Syn Promotes Ca 2؉ -and Complex I-dependent Mitotoxicity AUGUST 1, 2014 • VOLUME 289 • NUMBER 31

JOURNAL OF BIOLOGICAL CHEMISTRY 21495
Because mature ␣Syn fibrils can be prepared easily and reproducibly, we asked whether the mechanical disruption of fibrils into small species can produce oligomers that are functionally similar to the prefibrillar oligomers present during the aggregation lag phase (above). We first generated recombinant human ␣Syn fibrils (see "Experimental Procedures") and characterized them by several techniques before and after sonication. Electron microscopy of non-sonicated fibrils revealed long, relatively uniform fibers hundreds of nm in length with diameters between 10 and 15 nm (Fig. 3A). In contrast, sonicated fibril samples were more heterogeneous and included short fibril fragments as well as spherical ␣Syn aggregates (Fig. 3B). Dynamic light scattering analysis revealed the average hydrodynamic radius of non-sonicated fibrils and sonicated fibrils to differ markedly at ϳ950.5 and ϳ40.0 nm, respectively (Fig. 3C, note the log scale). We examined the ensemble aggregation state of sonicated ␣Syn by incubating samples with the ␤-sheet-binding dye ThT. Sonicated ␣Syn was only 10% as fluorescent as non-sonicated fibrils (Fig.  3D), illustrating a very substantial loss of ␤-sheet content. Despite this decrease in ␤-sheet content, we observed that sonicated ␣Syn fibrils were able to seed the aggregation of monomeric ␣Syn (Fig. 3E), confirming that they still contained species that can serve as a template for further aggregation.
Sonicated ␣Syn Fibrils Recapitulate the Mitochondrial Effects of Prefibrillar ThT neg ␣Syn-We compared sonicated and nonsonicated fibrils for their ability to alter the biochemical function of mitochondria. Under complex I conditions, sonicated ␣Syn reduced mitochondrial CRT in a dose-dependent manner, with the 1 and 2 M doses causing significant 14 and 21% reductions, respectively (Fig. 4, A and B). This CRT reduction was again associated with commensurate acceleration in membrane depolarization, oxidation of endogenous pyridine nucleotides, and swelling of the mitochondria (Fig. 4A). In contrast to the sonicated material and in agreement with the ThT pos samples described above (Fig. 1D), non-sonicated ␣Syn fibrils did not significantly alter CRT (Fig. 4C) or the three other mitochondrial parameters we measured (data not shown). Under complex II conditions, neither 1 nor 2 M sonicated ␣Syn led to a reduction in CRT or accelerated depolarization when incubated with mitochondria (Fig. 4, D and E). Together, these data confirm that relatively small oligomeric ␣Syn species, but not ThT pos fibrillar ␣Syn, promotes Ca 2ϩ -induced mitochondrial dysfunction specifically under complex I conditions.
In general, the reduction of CRT by sonicated ␣Syn (1 M) under complex I conditions was highly reproducible, but in 4 of 23 samples tested, no effect of the ␣Syn preparation could be detected. In the detailed characterization of the effects of ␣Syn on mitochondria that follows, we analyzed data from all of  ␣Syn Promotes Ca 2؉ -and Complex I-dependent Mitotoxicity AUGUST 1, 2014 • VOLUME 289 • NUMBER 31 those sonicated preparations that were found to be bioactive (i.e. 19 of 23).
Bioactivity of Sonicated ␣Syn Is Contained within a 100,000 ϫ g Supernatant-We sought to further define the bioactive component of the sonicated ␣Syn fibril preparation. Analysis of the CRT reduction capability of the 16,000 ϫ g supernatant revealed that it contained equivalent bioactivity compared with the total sonicated material (data not shown). To determine whether the active component was retained in a high speed supernatant, we fractionated the total sonicated material via ultracentrifugation at 100,000 ϫ g. Electron microscopy of the 100,000 ϫ g-soluble and -insoluble fractions showed a nearly complete separation of small, rounded particles and longer amyloid fibril fragments into the supernatant and pellet, respectively (Fig. 5, A and B). Further analysis using dynamic light scattering revealed that the 100,000 ϫ g supernatant contained oligomers with a mean hydrodynamic radius of 20.3 nm compared with monomeric ␣Syn and the 100,000 ϫ g pellet, which had mean hydrodynamic radii of 3.8 and 42.8 nm, respectively (Fig. 5C). Moreover, the 100,000 ϫ g supernatant was able to seed the aggregation of monomeric ␣Syn much faster than did additional monomer (Fig. 5D), suggesting that it contains misfolded species that can promote the conversion of unfolded protein into ␤-sheet-rich aggregates. Importantly, when applied to mitochondria, the 100,000 ϫ g supernatant significantly reduced CRT to a degree equivalent to the total sonicated sample, whereas the volume-normalized pellet failed to reduce CRT (Fig. 5E). Although the pellet contained considerably less material than the supernatant as determined by total protein assays, subsequent experiments showed that the protein in the pellet had no capability to decrease CRT when protein normalized (data not shown). Together, these data demonstrate that sonication of ␣Syn fibrils produces entirely soluble (non-pelletable) oligomers that can disrupt mitochondrial Ca 2ϩ homeostasis, whereas larger ␣Syn species that pellet under these conditions (intact fibrils and larger fragments thereof) have no significant effect on mitochondrial function.

Sonicated Fibrils Promote Ca 2ϩ -mediated Mitochondrial Dysfunction and Associated Cytochrome c Release via Permeability Transition
Pore Induction-There is mounting evidence that under pathophysiological conditions within a cell, the exposure of mitochondria to elevated cytosolic Ca 2ϩ can result in mitochondrial damage via a permeability transition mechanism (50 -52). The induction of opening of the mPTP is associated with membrane depolarization and release of intramitochondrial Ca 2ϩ . These changes are followed closely by the rupture of the outer mitochondrial membrane and subsequent release of cytochrome c, which in an intact cell could lead to the downstream initiation of apoptosis (53). To ascertain whether the opening of the mPTP was responsible for the ␣Syn-induced and Ca 2ϩ -mediated changes in mitochondrial parameters documented above, we examined the effect of the specific mPTP inhibitor cyclosporin A (CsA). As expected, preincubation of the mitochondria with 1 M CsA prevented the CRT reduction by sonicated ␣Syn fibrils (Fig. 6A, left, purple trace) and the associated decrease in the time to complete mitochondrial swelling (Fig. 6A, right, purple trace). We next determined whether the earlier onsets of mitochondrial Ca 2ϩ release and swelling caused by incubation with sonicated ␣Syn oligomers were accompanied by premature cytochrome c release. We removed aliquots of the vehicle-and ␣Syn-treated mitochondrial suspensions at time points corresponding to ϳ25, 50, 75, and 100% swelling of vehicle-treated mitochondria. Another aliquot was removed following the addition of alamethicin, which was used to induce maximal swelling and cytochrome c release. Western blots of the supernatants from all of these aliquots indicated that the detection of released cytochrome c correlated with the degree of swelling (change in light scattering) in the mitochondrial suspension as a whole (Fig. 6B). Importantly, CsA preincubation also prevented ␣Syn-induced cytochrome c release (Fig. 6B), suggesting that, in our system, this swelling occurs as a consequence of mPTP opening rather than via direct membrane permeabilization by ␣Syn oligomers.
We then used electron microscopy to confirm the protective effects of CsA on ␣Syn-induced swelling. Mitochondria at baseline (before the Ca 2ϩ addition) appeared dark with electrondense, compact cristae (Fig. 7A). Electron micrographs of vehicle-and ␣Syn-treated mitochondria samples fixed after complete reduction in absorbance (as determined by the fluorimeter) showed similar evidence of swelling (Fig. 7, B and C). We observed a qualitative lightening of the mitochondria caused by a loss of solutes as well as an increase in mitochondrial diameter. After swelling, the average diameters of ␣Synand vehicle-treated mitochondria were significantly larger than samples obtained at baseline but were not different from each other (Fig. 7E). Microscopy confirmed that preincubation of mitochondria with CsA prevented the loss of solutes and membrane swelling associated with permeability transition (Fig.  7D). In the presence of CsA, the average diameter of ␣Syn-treated mitochondria was not significantly different from mitochondria at baseline, suggesting that, in our system, ␣Syn-induced changes to mitochondrial diameter are dependent on the mPTP opening rather than direct, gross perturbation of mitochondrial membranes (Fig. 7E).
Activity of Sonicated ␣Syn Is Dependent on Exogenous Ca 2ϩ Uptake-Thus far, we had only investigated whether ␣Syn can alter mitochondrial function in the presence of exogenously added Ca 2ϩ . We therefore asked whether the ability of sonicated ␣Syn to alter mitochondrial function under complex I conditions was dependent on added Ca 2ϩ . For this purpose, we incubated the isolated mitochondria with sonicated ␣Syn but without the addition of exogenous Ca 2ϩ . No changes in all four measured mitochondrial parameters (⌬⌿ m , Ca 2ϩ flux, NAD(P)H oxidation state, and swelling) were detected for incubation times up to 1 h (Fig. 8A). To confirm that effects of sonicated ␣Syn are mediated by exogenous Ca 2ϩ , we asked whether sonicated ␣Syn fibrils sensitized mitochondria to a non-Ca 2ϩ inducer of mPTP opening, the bifunctional hydrophobic thiol-cross linking agent phenylarsine oxide (54). As in the absence of exogenous Ca 2ϩ , we observed no sensitizing effect of ␣Syn in the presence of 1 or 10 M phenylarsine oxide (PhAsO; Fig. 8B), suggesting that prefibrillar ␣Syn does not sensitize to all subtoxic stressors.
We then specifically tested whether Ca 2ϩ uptake into mitochondria, rather than simply its presence in the mitochondrial suspension, was required to observe ␣Syn-induced changes to mitochondrial parameters. Preincubation with the specific inhibitor of the mitochondrial Ca 2ϩ uniporter Ru360 (10 M) was sufficient to completely block uptake of exogenous Ca 2ϩ (Fig. 9A, compare bottom and top panels) and prevent the mPTP-inducing effects of sonicated ␣Syn, as exemplified by the swelling traces shown in Fig. 9B. We observed no reduction in absorbance over time, indicating that ␣Syn did not promote mitochondrial swelling in the presence of Ru360 (compare top and bottom panels of Fig. 9B). To determine whether exogenous Ca 2ϩ enhanced the physical association of ␣Syn with mitochondria, we incubated mitochondria with sonicated ␣Syn in the presence or absence of 20 M Ca 2ϩ , ran the lysate of extensively washed mitochondrial pellets on SDS-PAGE, and blotted for ␣Syn. We observed no differences in the intensity or pattern of ␣Syn immunoreactivity in the lysed mitochondrial pellet (Fig. 9, C (lanes L) and D). This indicates that, whereas Ca 2ϩ uptake is necessary for the downstream functional consequences of the ␣Syn/mitochondria association (i.e. CRT reduction and sensitization to mPTP opening), the association itself is not regulated by Ca 2ϩ under our conditions. These data suggest that the addition of Ca 2ϩ and the concomitant metabolic changes that accompany its uptake into mitochondria make the mitochondria vulnerable to the effects of bound ␣Syn.
Sonicated ␣Syn Impairs Complex I Activity-We have shown that sonicated ␣Syn fibril fragments impair complex I-dependent mitochondrial function. One potential explanation for this is that ␣Syn interferes with proper electron transport at complex I. To test this, we measured the enzymatic activity of complex I directly using the autofluorescence of its substrate NADH. This assay is independent of substrate availability or the activity of other respiratory complexes that factor into our Ca 2ϩ retention assays. We observed that sonicated ␣Syn, but not monomeric or fibrillar ␣Syn, significantly reduced the rate of rotenone-sensitive NADH oxidation (measured by loss of autofluorescence at 340 nM) of the isolated liver mitochondria used in our other experiments (Fig 10, A and B). These data support the notion that impaired complex I activity contributes to the reduction in Ca 2ϩ retention caused by sonicated ␣Syn under complex I conditions.
Based on this ability of sonicated ␣Syn to reduce complex I activity, we tested whether ␣Syn-induced reduction in Ca 2ϩ retention was associated with increased production of reactive oxygen species (ROS). High activity of catalase in liver mitochondrial preparations (55) makes it difficult to detect H 2 O 2 in this system. Catalase is generally less abundant in isolated brain mitochondria. Thus, we chose to examine ROS production by isolated brain mitochondria in the presence of Ca 2ϩ plus either vehicle or sonicated ␣Syn. We first confirmed that sonicated ␣Syn does indeed reduce Ca 2ϩ retention of brain mitochondria under complex I conditions. Because of the limited ability of brain-derived mitochondria to undergo swelling (56), we quantified the CRC, a widely used measure of a permeability transition-like event (40,57), rather than CRT. In this assay, additional Ca 2ϩ aliquots are needed to promote permeability transition at the population level. Sonicated ␣Syn reduced the CRC of brain mitochondria by ϳ22% under complex I conditions (Fig. 11, A and B), thus reproducing our key finding from liver mitochondria. We were able to simultaneously measure ROS production by adding Amplex Red to the assay buffer. However, despite their consistent ability to reduce CRC, sonicated ␣Syn oligomers did not increase the rate of H 2 O 2 production in this system (Fig. 11, C and D), suggesting either that incubation of mitochondria with prefibrillar ␣Syn in the presence of Ca 2ϩ does not increase ROS or that any increased ROS production induced by prefibrillar ␣Syn could not be detected under our experimental conditions.

DISCUSSION
Evidence from many laboratories makes it increasingly clear that mitochondria are a principal target for aberrant accumulation of ␣Syn within the cell (27, 29 -32, 36, 37, 58, 59). However, few studies have investigated the effects of different assembly forms of ␣Syn directly on the function of mitochondria. Here, we used a reductionist model system comprising ␣Syn Promotes Ca 2؉ -and Complex I-dependent Mitotoxicity isolated liver and brain mitochondria and different, well characterized forms of pure human ␣Syn to discover that highly soluble, prefibrillar ␣Syn oligomers, but not monomers or ThT pos fibrils, impair mitochondrial function. Further, we show that the toxicity of oligomeric ␣Syn is specifically dependent on both mitochondrial uptake of exogenous Ca 2ϩ and electron flow through complex I.
The literature is replete with protocols for preparing ␣Syn oligomers (e.g. by incubation with supraphysiological levels of metal ions, lipids, detergents, or oxidizing agents) that are either not further characterized or vary in their morphological, biochemical, and/or functional characteristics (12, 60 -65). In this study, we report highly complementary results using two independent methods for generating soluble prefibrillar ␣Syn oligomers in the absence of any additives: sonication of fully formed amyloid fibrils (sonicated preparation) and collection of oligomers during the lag phase of initial aggregation (lag phase preparation). Although oligomers obtained with the sonicated preparation are formed by the sonication of fibrils and could therefore be considered "postfibrillar," they are capable of seeding the aggregation of monomeric protein into ThT pos fibrils. Thus, for simplicity and to distinguish them from physiological, aggregation-resistant helical oligomers (7,9), we refer herein to oligomers from the sonicated and lag phase preps as "prefibrillar oligomers." Both of these preparations produce closely similar effects on mitochondrial function, which argues against the likelihood of artifactual effects caused by a specific preparation of oligomers. Under the specific conditions discussed further below, ␣Syn generated using either of our protocols recapitulated several mitochondrial phenotypes previously reported in animal and cell models of PD, namely complex I-mediated dysfunction, altered ⌬⌿ m , disrupted Ca 2ϩ homeostasis, and enhanced cytochrome c release. Our development of simple protocols to generate and enrich for pathologically relevant oligomeric ␣Syn provides an approach for more efficiently studying ␣Syn cytotoxicity, including further investigations into the mechanisms of mitochondrial dysfunction.
Collectively, our data indicate that highly soluble prefibrillar oligomers, rather than larger, 100,000 ϫ g-pelletable assemblies or fibril fragments, can disrupt proper mitochondrial function. ThT assays suggest that our bioactive material is not ␤-sheet-rich; however, we cannot exclude the possibility that a small percentage of ␤-sheet-containing oligomers that do not avidly bind ThT contribute to our observed effects, especially in light of a propensity of the active material to act as a template for the formation of ␤-sheet-containing amyloid fibrils. Our results provide a potential subcellular target of prefibrillar ␣Syn oligomers recently reported to be cytotoxic in cellular and animal  A, mechanically disrupted mitochondria were incubated with vehicle (black), monomeric ␣Syn (blue), sonicated ␣Syn fibrils (red), or intact fibrils (green), and the oxidation of supplied NADH was monitored by the absorbance at 340 nm before and after the addition of rotenone (indicated by the dashed line). The post-rotenone absorbance slope was subtracted from the pre-rotenone slope to obtain the rotenonesensitive activity. B, rotenone-sensitive complex I activity in mitochondria incubated with various ␣Syn forms was normalized to vehicle-treated mitochondria. Error bars, S.D. of three independent experiments. *, p Ͻ 0.05 when compared with all other groups, ANOVA followed by Tukey's multiple comparisons test.
␣Syn Promotes Ca 2؉ -and Complex I-dependent Mitotoxicity models. Karpinar et al. (14) reported greater oligomerization propensity but reduced fibrilization and ␤-sheet content of recombinant ␣Syn engineered to contain various proline substitutions. Overexpression of these mutants in rat primary neurons, Caenorhabditis elegans, and Drosophila was associated with neurotoxicity that was inversely proportional to the ␤-sheet content of in vitro oligomers of the same ␣Syn proteins (14), but mitochondrial dysfunction was not specifically addressed. Recent work by Winner et al. (13) is also in line with our findings; ␣Syn mutants that preferentially form ␤-sheetpoor oligomers rather than ␤-sheet-rich fibrils in vitro were associated with more neurotoxicity in lentivirus-infected human mesencephalic cells and rat brain. Moreover, interaction of these oligomers with cellular membranes was suggested as a potential mediator of toxicity (13), but again mitotoxicity was not examined. Our sonicated preparation was modeled in part after the sonicated preformed fibrils used by Lee and colleagues (48,49), who demonstrated the internalization of extraneuronally applied sonicated fibrils and their ability to promote the aggregation of endogenous ␣Syn. To date, the colocalization, if any, of the seeded protein with mitochondria and the possible functional consequences for these organelles have not been assessed, but in light of our findings, they should be.
Prefibrillar ␣Syn represents a heterogeneous pool of transient oligomeric species on their way to highly ordered, ␤-sheet aggregates analogous to those comprising the fibrils in Lewy bodies and Lewy neurites (11,60). Thus, our results are in agreement with the concept of Lewy pathology as a relatively protective mechanism, at least temporarily (66,67). In the context of PD, our data support the pursuit of therapeutic strategies designed to stabilize native, aggregation-resistant ␣-helical tetramers and related oligomers in neurons (7,9). Alternatively, one could attempt to accelerate the fibrilization process to decrease levels of potentially toxic oligomers, although it is likely that these species are in equilibrium, and the fibrils could later release smaller oligomers that could promote aggregation of monomeric protein via a secondary nucleation mechanism (47,68).
The mitochondria of neurons of the substantia nigra pars compacta and other brain regions vulnerable to PD are subjected to high Ca 2ϩ concentrations due to regular influx through pacemaking L-type channels and low expression of FIGURE 11. Sonicated ␣Syn reduces the Ca 2؉ retention of brain mitochondria without measureable enhancement of ROS production. A, representative traces of the Ca-Green 5N fluorescence of vehicle-treated (black) and 2 M sonicated ␣Syn-treated brain mitochondria (red) under complex I conditions. ␣Syn-treated mitochondria were able to buffer fewer Ca 2ϩ additions to the solution. B, quantification of the relative CRC of vehicle-and sonicated ␣Syn-treated mitochondria. Error bars, S.D. from eight independent experiments. *, p Ͻ 0.05 using Student's t test. C, ROS production from vehicle-treated (black) and sonicated ␣Syn-treated (red) mitochondria (left) was measured using the dye Amplex Red concurrently with CRC (right). D, the mean slopes of the increase in Amplex Red fluorescence during Ca 2ϩ accumulation were quantified. Despite its ability to reduce CRC, sonicated ␣Syn did not lead to a significant increase in ROS production in this system. Error bars, S.D. of five independent experiments.
␣Syn Promotes Ca 2؉ -and Complex I-dependent Mitotoxicity AUGUST 1, 2014 • VOLUME 289 • NUMBER 31 cytosolic Ca 2ϩ -buffering proteins (25,26,69). We therefore studied the effects of ␣Syn on mitochondrial function in the context of elevated Ca 2ϩ levels. We observed that bioactive prefibrillar ␣Syn disrupted basic mitochondrial parameters (⌬⌿ m , Ca 2ϩ uptake/release, redox state of pyridine nucleotides, and swelling) only in the presence of exogenously added Ca 2ϩ . Because Ru360 abolished this effect, we can conclude that the downstream effects of mitochondria-associated ␣Syn were dependent on the uptake of Ca 2ϩ into the mitochondrial matrix. Previous reports suggest that overexpressing ␣Syn in cells or animals leads to alterations in mitochondrial morphology or function in the absence of overt Ca 2ϩ stress (27,31,36,37,58,59,70,71). These results could be explained by one or more of the following possibilities. First, toxic ␣Syn species could affect the function of other organelles, such as the endoplasmic reticulum (71), or cellular pathways leading to intracellular Ca 2ϩ dyshomeostasis. Second, when overexpressed in cell lines or animals (versus briefly incubated with mitochondria in vitro as here), there may be greater opportunity for ␣Syn to exert its effects, so that mild alterations of mitochondrial function (which could be exacerbated by our acute Ca 2ϩ challenge) can accumulate chronically. In this context, physiological Ca 2ϩ transients in neurons could be a sufficient stress in the presence of prefibrillar, oligomeric ␣Syn. Furthermore, endogenous toxins, such as the monoamine oxidase-generated product of dopamine, 3,4-dihydroxyphenylacetaldehyde, have also been shown to facilitate mitochondrial permeability transition (72) and may act synergistically with pathological ␣Syn in dopaminergic neurons. Third, the ability of Ca 2ϩ to exacerbate the mitochondrial effects of ␣Syn may not be due to Ca 2ϩ uptake per se but rather the associated increase in ETC activity. Mitochondrial Ca 2ϩ influx comes at the expense of ⌬⌿ m , which must be reestablished in order to generate ATP and buffer further Ca 2ϩ loads. One possibility is that proper ETC function may be disrupted by ␣Syn (see below), and the increased ETC activity needed to restore ⌬⌿ m in response to the uptake of excess Ca 2ϩ could increase the generation of ROS, thereby accelerating mPTP opening. However, we did not observe an elevation in ROS production in our preliminary experiments. Mitochondria targeted by prefibrillar ␣Syn may be less able to reestablish ⌬⌿ m and would therefore be more susceptible to permeability transition; reduced ⌬⌿ m is a known sensitizing factor for mPTP opening (73,74). Our direct measurements of complex I activity, obtained under conditions of rapid electron flux, are supportive of this hypothesis. They suggest that prefibrillar ␣Syn can reduce the maximal enzymatic activity and impair mitochondrial function in the absence of Ca 2ϩ if ETC activity is otherwise increased.
The protective effects of CsA on our ␣Syn-induced changes in mitochondrial parameters demonstrated that the addition of prefibrillar ␣Syn sensitized mitochondria to mPTP activation. The acceleration of cytochrome c release in ␣Syn-treated mitochondria was likewise rescued by preincubation with CsA. This result suggests that cytochrome c release was also regulated by the mPTP in our system rather than by channels formed via direct permeabilization of the outer membrane by oligomeric ␣Syn, as has been suggested (75). Although the role of mitochondrial permeability transition in PD-related cell death requires further study, two recent reports support the in vivo relevance of our data. Findings from Martin et al. (32) indicate that the genetic ablation of cyclophilin D, the mPTP modulator and target of CsA, delayed the onset of mitochondrial abnormalities and neuronal apoptosis in Thy1-␣Syn A53T transgenic mice. Also, Büttner et al. (33) showed that overexpression of ␣Syn in yeast led to cell death and a redistribution of the proapoptotic nuclease EndoG from mitochondria to the nucleus, and these effects could both be rescued by genetic modulation of the mPTP components. ␣Syn-induced, EndoG-dependent cytotoxicity was also observed in C. elegans, flies, and human neuroblastoma cells. Moreover, nuclear translocalization of EndoG was preferentially detected in the brain sections of PD patients compared with age-matched controls (33). Others have recently proposed that WT ␣Syn binds to mitochondriaassociated endoplasmic reticulum membranes rather than mitochondria themselves (76). However, the authors did see a redistribution of ␣Syn to "pure" mitochondria under pathological conditions, when the oligomer-promoting mutants A53T and A30P were overexpressed in both HeLa cells and mouse brain. Overexpression of these mutants was also associated with altered mitochondrial morphology (76).
Ca 2ϩ -induced mPTP opening can be broadly split into three main phases that could be accelerated by ␣Syn based on our new work: the "initiation phase," during which Ca 2ϩ is taken up into the matrix through the mitochondrial Ca 2ϩ uniporter; the "lag phase," during which mPTP components are recruited and assembled; and the "propagation phase," during which mPTP induction spreads through the population (39). Inducers can affect one or more phases, and even highly related compounds can show differential effects (39,77). Our data showing the lack of direct effect of ␣Syn on ⌬⌿ m and the unimpaired initial uptake of Ca 2ϩ both suggest that the first phase is not significantly affected by ␣Syn. The relatively long, stable lag phase even in the presence of prefibrillar ␣Syn is also consistent with a minimal effect (if any) in the initial phase. There is also no apparent shift in the slope of the final propagation phase, suggesting no significant effect on that aspect of mPTP induction. This suggests that ␣Syn primarily acts during the lag phase. Accordingly, the lag phase is significantly shortened in our ␣Syn-treated mitochondria.
Alteration of the lag phase by prefibrillar oligomers is also consistent with our observing a clear cut respiratory substratedependent effect. Our results show that prefibrillar ␣Syn oligomers sensitize mitochondria to Ca 2ϩ -induced permeability transition under complex I but not complex II conditions. In light of our findings and existing literature (27,35,58), the most likely explanation for these findings is that ␣Syn acts to inhibit complex I. It has been reported that the brain mitochondria of A53T transgenic mice show reduced complex I activity when compared with wild type (78). The degree of reduction did not correlate with age-dependent ␣Syn deposition in the mice or with the apparent level of SDS-resistant oligomers (78). It is possible that (a) the results were confounded by the loss of the cells in which complex I dysfunction was exacerbated by age, (b) only a small population of the total brain cells (e.g. nigral dopaminergic neurons) showed an age-dependent reduction in complex I activity, or (c) a "ceiling effect" occurred (i.e. the initial accumulation of ␣Syn oligomers in the brain already produced a maximal reduction of complex I function). Prefibrillar ␣Syn oligomers could act to inhibit complex I function either directly or indirectly via perturbations of mitochondrial membrane lipids. The well demonstrated tendency of ␣Syn to bind acidic phospholipids, especially cardiolipin (79), which is critical for proper electron transfer by complexes I and III (80,81), suggests that membrane association of pathological ␣Syn oligomers could destabilize complex I activity. Flux through complex I would be expected to be more sensitive to this interaction/inhibition because it is more rate-limiting (82). In the context of energization with a complex I substrate, even mild inhibition could be detrimental to mitochondria depolarized by Ca 2ϩ uptake. Restoration and maintenance of the ⌬⌿ m , a primary defense against mPTP opening, would require increased electron flow into a compromised complex I.
Flux into and/or through an impaired complex I could also be expected to lead to initiation of a feed-forward cycle of increasing ROS generation and worsening complex I function. We did not detect elevated ROS production by prefibrillar ␣Syn in our system, but it is conceivable that extensive optimization of assay conditions could allow for more sensitive measurement of small changes in ROS generation.
In summary, we demonstrate for the first time a direct link between a particular form of ␣Syn assembly and mitochondrial dysfunction in a system that models the Ca 2ϩ phenotype of cells affected in PD. Our data suggest that, in the context of PD, alterations in ␣Syn proteostasis that destabilize physiological ␣-helical oligomers or otherwise shift the equilibrium toward aggregation-prone monomeric ␣Syn may drive the generation of mitotoxic prefibrillar oligomers that contribute to complex I-dependent dysfunction and the resultant degeneration of vulnerable neuronal populations.